IN2013MU01336AIN1336MU2013AIN2013MU01336AIN 2013MU01336 AIN2013MU01336 AIN 2013MU01336AIN 1336MU2013 AIN1336MU2013 AIN 1336MU2013AIN 2013MU01336 AIN2013MU01336 AIN 2013MU01336A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare LtdfiledCriticalCadila Healthcare Ltd
Priority to IN1336MU2013priorityCriticalpatent/IN2013MU01336A/en
Priority to PCT/IN2014/000219prioritypatent/WO2014178068A2/en
Publication of IN2013MU01336ApublicationCriticalpatent/IN2013MU01336A/en
An improved process for preparation of n-[1-(1-naphthyl)ethyl] -3- [3-(trifluoromethyl)phenyl]propan-1-amine and pharmaceutically acceptable salts thereof
Derivados de 3-acetilamino-1 (fenil-heteroaril-aminocarbonil o fenil-heteroaril-carbonilamino) benceno para el tratamiento de desordenes hiperproliferativos
A method for the preparation of derivatives of 5,3-diamino-6-chloro-2-(aralkylbutyl-carbamimidoyl)pyrazine, several such compounds and their intermediates
An improved process for preparation of n-[1-(1-naphthyl)ethyl] -3- [3-(trifluoromethyl)phenyl]propan-1-amine and pharmaceutically acceptable salts thereof
New process for synthesis of 3-(2-bromo-4,5-dimethoxybenzyl) propanenitrile, and application in synthesis of ivabradine and addition salts therewith pharmaceutically acceptable acid
Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl) ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same
Novel method for synthesis of 3-(2-bromo-4,5-dimethoxy phenyl)propanenitrile, usage thereof and pharmaceutically acceptable acid-additive salts thereof